Identification of mutagenic site of c-H-ras oncogene damaged by N-acetoxyacetylaminofluorene(AAAF) .
10.3349/ymj.1991.32.3.207
- Author:
Sang Hwan OH
1
;
Kun Hong KIM
;
Seo Eun LEE
;
Byung Il YEH
Author Information
1. Department of Biochemistry, Yonsei University College of Medicine, Seoul, Korea.
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
c-H-ras oncogene;
AAAF;
mutation
- MeSH:
Acetoxyacetylaminofluorene/*pharmacology;
Chromatography, Thin Layer;
Codon;
*DNA Damage;
Electrophoresis, Agar Gel;
Genes, ras/*drug effects/genetics;
Human;
Mutagenesis, Site-Directed;
Oligonucleotide Probes;
Plasmids/drug effects/genetics;
Polymorphism, Restriction Fragment Length
- From:Yonsei Medical Journal
1991;32(3):207-214
- CountryRepublic of Korea
- Language:English
-
Abstract:
A molecularly cloned human cellular H-ras (c-H-ras) oncogene(pbc N1 plasmid) was treated with N-acetoxyacetylaminofluorene (AAAF) in vitro and subcloned into E.coli. This was done to identify the mutational changes at specific codons of the gene. Guanine nucleotides were identified as the major AAAF binding site of the DNA adduct formed. Base changes in codons 12 and 61 were determined by the analysis of restriction fragment length polymorphism (RFLP) and site specific oligonucleotide hybridization. RFLP was observed due to the loss of the Hpall recognition site at codon 11 and 12 of AAAF-treated c-H-ras gene. Hybridization of AAAF treated c-H-ras with 32P-labeled oligonucleotide probes for the mutant alleles of codon 61 showed no substitutions at codon 61. From these results, it is assumed that AAAF treatment in vitro caused mutation at codon 12 but not at codon 61 of the c-H-ras oncogene and that codon 12 is the primary target of mutation by AAAF
